GA-SYSNET-GLOBAL-SOL
6.2.2020 14:02:11 CET | Business Wire | Press release
Sysnet Global Solutions , the leading provider of cyber security and compliance solutions operating in over 60 countries worldwide, today announced it has secured a significant growth equity investment led by FTV Capital , a growth equity firm with a successful track record supporting high-growth financial services and technology companies, and joined by equal investor True Wind Capital , a technology-focused growth and private equity firm with significant experience in security software and services. As part of the transaction, FTV Capital founding partner Richard Garman, partner Kyle Griswold and principal Richard Liu will join Sysnet’s board of directors. From True Wind, founding partner Jamie Greene and partner Sean Giese will join Sysnet’s board of directors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200206005486/en/
Sysnet provides merchant compliance and security management solutions to some of the world’s largest, global acquiring organisations, supporting more than 3 million merchants worldwide. Sysnet clients favour Sysnet’s managed compliance and security services as an alternative to charging customers non-compliance fees for not complying with the PCI DSS (Payment Card Industry Data Security Standards). Any organisations that handles payment card data must comply with PCI DSS.
The investment will be used to support Sysnet’s rapid growth in North America and Europe, as well as its expansion into new markets including Latin America and Asia. The investment will also accelerate the development of its security product offerings to SMBs via acquiring and payment processing organisations.
“Sysnet is delighted to align with world-class partners like FTV Capital and True Wind Capital to support growth plans in both existing and new markets,” said Gabe Moynagh, CEO at Sysnet, “FTV is a perfect fit for Sysnet given its knowledge of security and payments, Global Partner Network® and proven ability to scale high-growth companies. Further, True Wind is a seasoned technology, software and security investor, providing decades of operational, growth and scaling expertise to technology companies. Their combined investment will enable us to deepen our strategic relationship with our clients and their customers through the enhancement of our security product offering and customer support globally. We‘re incredibly confident that Sysnet will benefit from the experience and expertise that the FTV and True Wind teams bring to the table.”
As a sector-specific growth investor, FTV Capital has deep domain expertise in the security and payments industries, having previously invested in other companies such as A-LIGN, Egress, ID.me, and ReliaQuest. True Wind Capital’s investment professionals have significant experience leading successful transactions in security software and managed IT services, including Crowdstrike, Datto, Zscaler, GoDaddy and Zix.
“As the need for cybersecurity and compliance solutions continues to skyrocket, businesses of all sizes require best-in-class solutions to meet this critical need,” said FTV Capital partner Kyle Griswold. “Sysnet has proven to be a continuous innovator in the space and provides a compelling solution to both payments providers in the form of better compliance and merchant retention and merchants in the form of better security and data protection.” True Wind Capital partner Sean Giese continued, “the company is primed for tremendous growth as it looks to serve businesses ranging in size from small to large, while expanding its global footprint and product set.”
“Sysnet is revolutionizing the way merchants meet payments standards across the globe,” commented FTV Capital founding partner Richard Garman. “With this investment, FTV Capital will use its security market experience and network to accelerate Sysnet’s innovations for the global transaction service industry.”
“We are at an exciting inflection point of Sysnet’s development. True Wind looks forward to partnering with both Sysnet’s management team and FTV to achieve this next stage of growth,” said True Wind Capital founding partner Jamie Greene.
According to the 2019 Global State of Cybersecurity in Small and Medium-Sized Businesses report, SMBs have reported a significant increase in targeted cybersecurity breaches for the third consecutive year. The report finds that attacks against U.S., U.K. and European businesses are growing in both frequency and sophistication. Sysnet helps SMBs to protect against such breaches by providing a managed service that assists such businesses in maintaining compliance with PCI DSS and by providing them with a range of security tools to protect their payment and business environment, all supported and monitored by a team of data security experts.
The Sysnet team was assisted in the transaction by DC Advisory, the Dublin office of the Maples Group, Jamieson Corporate Finance, and Ernst & Young.
*The Nilson Report “Largest 150 Merchant Acquirers Worldwide”
# ENDS #
Notes to Editor
About Sysnet
Established in 1989, Sysnet Global Solutions provides payment card industry, cyber security and compliance solutions that help businesses to improve security and acquiring organisations to reduce risk. Specialising in data security and PCI DSS compliance validation solutions, Sysnet offers a range of services, including its award-winning, Sysnet.air® Proactive Data Security compliance and security management solution to a wide variety of businesses including acquirers, ISOs, international banks, payment service providers and merchants. Headquartered in Dublin, Ireland, Sysnet has clients in more than 60 countries worldwide. Connect with Sysnet on LinkedIn , follow on Twitter . Subscribe to the Blog . www.sysnetgs.com .
About FTV Capital
FTV Capital is a growth equity investment firm that has raised more than $2.7 billion to invest in high-growth companies offering a range of innovative solutions in three sectors: enterprise technology and services, financial services, and payments and transaction processing. FTV’s experienced team leverages its domain expertise and proven track record in each of these sectors to help motivated management teams accelerate growth. FTV also provides companies with access to its Global Partner Network®, a group of the world’s leading enterprises and executives who have helped FTV portfolio companies for two decades. Founded in 1998, FTV Capital has invested in over 110 portfolio companies, including a number in the security sector, including Security Compass, Egress, ID.me, ReliaQuest, A-LIGN, and exited companies Trustwave (acquired by SingTel in 2015) and CardConnect (acquired by First Data in 2017). Current financial services investments companies include Clearent, a merchant payment processing company, and EBANX, a cross-border payments platform. FTV has offices in San Francisco and New York. For more information, visit www.ftvcapital.com. Follow @FTVCapital on Twitter or connect with FTV on LinkedIn .
About True Wind Capital
True Wind Capital is a San Francisco-based private equity firm focused on investing in leading technology companies with a broad mandate including software, data analytics, tech-enabled services, internet, financial technology, and hardware. True Wind Capital is a value-added partner, providing support and expertise that is rooted in its teams’ 75+ years of collective investing experience. True Wind’s founding partners have successfully invested more than $15 billion of equity in transactions with over $75 billion of value across a variety of industries, geographies, economic cycles and transaction types. True Wind Capital investments include Transflo, Zix and ARI Network Services. Visit www.truewindcapital.com for more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200206005486/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
